Latest News and Press Releases
Want to stay updated on the latest news?
-
JERSEY, Channel Islands, May 31, 2016 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the company’s Chairman & CEO, Paul Cowan,...
-
Completed commissioning of initial manufacturing system for MosaiQTM consumablesFirst field trial instruments received for internal evaluation and validationGenerated positive study results for...
-
JERSEY, Channel Islands, May 11, 2016 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that financial results for its fourth...
-
JERSEY, Channel Islands, May 11, 2016 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the company’s Chairman & CEO, Paul Cowan,...
-
JERSEY, Channel Islands, April 21, 2016 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that its U.S. subsidiary, Quotient...
-
JERSEY, Channel Islands, April 13, 2016 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that results generated using the MosaiQTM...
-
Initial Manufacturing System for MosaiQ™ Consumables Successfully CommissionedFirst MosaiQ™ Field Trial Instruments Built and Received for Internal Evaluation JERSEY, Channel Islands, April 13,...
-
Considerable progress on development and commercial scale-up of MosaiQ™, Quotient’s next-generation automation platform for transfusion diagnosticsMarketing of MosaiQ™ expected to start in the...
-
JERSEY, Channel Islands, Feb. 04, 2016 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced the pricing of an underwritten public offering of...
-
JERSEY, Channel Islands, Feb. 03, 2016 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that it intends to commence an underwritten...